| Description |
1 online resource : illustrations (black and white, and colour) |
| Series |
SAGE knowledge. Cases |
|
SAGE knowledge. Cases
|
| Summary |
Morgan Life Sciences was a biotechnology firm headquartered in Waltham, Massachusetts. Initially, it focused on generic and over-the-counter medications, which it manufactured and distributed to drugstores and supermarket chains. Morgan completed a successful initial public offering in 1994, but by the late 1990s, the generics market had become increasingly competitive. Morgan steadily lost ground as its larger, low-cost competitors pushed prices relentlessly downward. This study explains how CEO Wendy Shaw set about transforming the fortunes of the company |
| Notes |
Originally Published in: Flaumenhaft, B., & Bagley, C.E. (2008). Morgan Life Sciences. 08-021. New Haven, CT: Yale School of Management, Yale University |
|
Online resource; title from home page (viewed on May 3, 2016) |
| Subject |
Morgan Life Sciences (Firm)
|
|
Organizational change -- Case studies
|
|
Business planning -- Case studies
|
|
Biotechnology industries -- Case studies
|
|
Biotechnology industries
|
|
Business planning
|
|
Organizational change
|
| Genre/Form |
Case studies
|
| Form |
Electronic book
|
| Author |
Bagley, Constance E., author
|
| ISBN |
9781473973343 |
|
1473973341 |
|
